Drug Shortage Report for RIVA-VERAPAMIL SR
Report ID | 1662 |
Drug Identification Number | 02248082 |
Brand name | RIVA-VERAPAMIL SR |
Common or Proper name | Verapamil Hydrochloride |
Company Name | LABORATOIRE RIVA INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE |
Strength(s) | 240MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C08DA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2016-10-20 |
Actual start date | 2016-10-20 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2017-10-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2017-03-13 | French | Compare |
v2 | 2017-03-13 | English | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 3 of 3